Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186561 · ClinicalTrials.gov registry record · NA
Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device
A NA study, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT02186561 is a NA study that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 197 participants.
The verdict
NCT02186561, a NA study, has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of the Pipeline™ device in the treatment of unruptured, wide-neck intracranial aneurysms.
Interventions
- DEVICE Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2014-07-24 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186561
The ClinicalTrials.gov registry entry for NCT02186561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device is the first listed.
NCT02186561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186561 about?
NCT02186561 is a clinical study titled "Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device". The purpose of this study is to assess the safety and effectiveness of the Pipeline™ device in the treatment of unruptured, wide-neck intracranial aneurysms.
What is the current status of trial NCT02186561?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2014-07-24. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT02186561?
The interventions under investigation include: Pipeline™ Embolization Device/ Pipeline™Flex Embolization Device (DEVICE).
Who is sponsoring clinical trial NCT02186561?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.